Kidney cancer news
Quality of life reporting in kidney cancer clinical trials
Quality-of-life (QoL) is very important to patients when they are [...]
Survival after second-line therapy in patients with metastatic kidney cancer treated with first-line immunotherapy combinations
This study looked at real world information from patients with [...]
Finding cancers missed during the pandemic
As many of you know, the COVID-19 pandemic has delayed [...]
NHS long-term workforce plan
Over 100 health and care organisations, including the Royal College [...]
Cost of living support for people with cancer
Macmillan have regularly updated information on support for people with [...]
Taking action on equalities in rare and less common cancers: Understanding the issues
More than half of all cancer deaths in the UK [...]
Most used tags
renal cell carcinoma immunotherapy checkpoint inhibitors combination therapy Cancer TKIs overall survival nivolumab Opdivo sunitinib Sutent progression-free survival cabozantinib biomarkers NHS England Cabometyx ipilimumab COVID-19 cancer survival axitinib pembrolizumab VEGF inhibitors Inlyta non-clear cell kidney cancer coronavirus Yervoy Keytruda risk factors metastases biological markers adjuvant therapy everolimus targeted therapy papillary RCC Afinitor ASCO first-line treatment cancer outcomes NICE partial nephrectomyArchives
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
